CO5611150A2 - Formulacion en aerosol de una sal de tiotropio de administracion directa para inhalacion - Google Patents

Formulacion en aerosol de una sal de tiotropio de administracion directa para inhalacion

Info

Publication number
CO5611150A2
CO5611150A2 CO04100971A CO04100971A CO5611150A2 CO 5611150 A2 CO5611150 A2 CO 5611150A2 CO 04100971 A CO04100971 A CO 04100971A CO 04100971 A CO04100971 A CO 04100971A CO 5611150 A2 CO5611150 A2 CO 5611150A2
Authority
CO
Colombia
Prior art keywords
tiotropium
drug preparation
salt
preparation according
acid
Prior art date
Application number
CO04100971A
Other languages
English (en)
Spanish (es)
Inventor
Karin Drechsel
Barbara Niklaus-Humk
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28458728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5611150(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of CO5611150A2 publication Critical patent/CO5611150A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Nozzles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CO04100971A 2002-04-11 2004-10-08 Formulacion en aerosol de una sal de tiotropio de administracion directa para inhalacion CO5611150A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10216036A DE10216036A1 (de) 2002-04-11 2002-04-11 Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz

Publications (1)

Publication Number Publication Date
CO5611150A2 true CO5611150A2 (es) 2006-02-28

Family

ID=28458728

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04100971A CO5611150A2 (es) 2002-04-11 2004-10-08 Formulacion en aerosol de una sal de tiotropio de administracion directa para inhalacion

Country Status (32)

Country Link
EP (2) EP1949892A1 (https=)
JP (1) JP2005531528A (https=)
KR (1) KR100997219B1 (https=)
CN (1) CN1309378C (https=)
AR (1) AR039286A1 (https=)
AT (1) ATE389391T1 (https=)
AU (1) AU2003222791B2 (https=)
BR (1) BR0309080A (https=)
CA (1) CA2473815C (https=)
CO (1) CO5611150A2 (https=)
CY (1) CY1108133T1 (https=)
DE (2) DE10216036A1 (https=)
DK (1) DK1496876T3 (https=)
EA (1) EA007228B1 (https=)
EC (1) ECSP045358A (https=)
ES (1) ES2303897T3 (https=)
HR (1) HRP20040932B1 (https=)
ME (1) ME00359B (https=)
MX (1) MXPA04009818A (https=)
MY (1) MY137249A (https=)
NO (1) NO334915B1 (https=)
PE (1) PE20030970A1 (https=)
PL (1) PL371204A1 (https=)
PT (1) PT1496876E (https=)
RS (1) RS50923B (https=)
SA (1) SA03240192B1 (https=)
SI (1) SI1496876T1 (https=)
TW (1) TWI344851B (https=)
UA (1) UA78994C2 (https=)
UY (1) UY27754A1 (https=)
WO (1) WO2003084519A2 (https=)
ZA (1) ZA200405721B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5165244B2 (ja) 2003-11-03 2013-03-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング チオトロピウム塩の製法、チオトロピウム塩及びそれを含有する医薬組成物
EP1915158A1 (en) * 2005-08-06 2008-04-30 Boehringer Ingelheim International GmbH Use of tiotropium salts in the treatment of severe persistant asthma
US20070088030A1 (en) 2005-10-10 2007-04-19 Barbara Niklaus-Humke Aerosol formulations for the inhalation of beta-agonists
EP1905440A1 (de) * 2006-09-06 2008-04-02 Boehringer Ingelheim Pharma GmbH & Co. KG Verwendung einer pharmazeutischen Zusammensetzung enthaltend ein Anticholinergikum zur Abtötung von Mikroorganismen und zur Behandlung von Atemwegsinfektionen
EP2044967A1 (de) * 2007-10-01 2009-04-08 Boehringer Ingelheim Pharma GmbH & Co. KG Zerstäuber
EP2819669B1 (de) 2012-02-28 2021-04-21 Boehringer Ingelheim International GmbH Neue treibgashaltige tiotropium-formulierung
RU2493827C1 (ru) * 2012-10-03 2013-09-27 Шолекс Девелопмент Гмбх Стабильный комбинированный раствор фенотерола гидробромида и ипратропия бромида
WO2015065219A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Раствор ипратропия бромида
WO2015065223A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Стабильный раствор фенотерола гидробромида
GB201507686D0 (en) * 2015-05-05 2015-06-17 Norton Healthcare Ltd A stable tiotropium nebuliser solution
CN109963557A (zh) * 2016-11-16 2019-07-02 格兰马克专业公司 雾化的噻托铵
CN115209872B (zh) * 2020-03-19 2024-08-02 广州谷森制药有限公司 含有酒石酸左旋沙丁胺醇的可吸入制剂
CN114259481A (zh) * 2021-11-26 2022-04-01 南京华盖制药有限公司 一种奥达特罗复方吸入溶液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
IL107120A (en) 1992-09-29 1997-09-30 Boehringer Ingelheim Int Atomising nozzle and filter and spray generating device
DE19536903C2 (de) 1995-10-04 1998-09-10 Boehringer Ingelheim Int Vorrichtung zum Haltern eines fluidischen Bauteils
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19545226C1 (de) 1995-12-05 1997-06-19 Boehringer Ingelheim Int Sperrspannwerk für einen federbetätigten Abtrieb
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19742439C1 (de) 1997-09-26 1998-10-22 Boehringer Ingelheim Int Mikrostrukturiertes Filter
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
CZ300794B6 (cs) * 2000-10-31 2009-08-12 Boehringer Ingelheim Pharma Gmbh And Co. Kg Farmaceutický prostredek a jeho použití jako inhalacní roztok

Also Published As

Publication number Publication date
ES2303897T3 (es) 2008-09-01
TW200401653A (en) 2004-02-01
MEP54308A (en) 2011-05-10
WO2003084519A2 (de) 2003-10-16
HRP20040932B1 (hr) 2013-04-30
MXPA04009818A (es) 2004-12-13
KR100997219B1 (ko) 2010-11-29
ME00359B (me) 2011-10-10
ECSP045358A (es) 2004-11-26
BR0309080A (pt) 2005-02-22
NO334915B1 (no) 2014-07-14
NO20044001L (no) 2004-10-27
DE10216036A1 (de) 2003-10-23
SA03240192B1 (ar) 2008-01-09
SI1496876T1 (sl) 2008-08-31
ZA200405721B (en) 2006-05-31
DE50309414D1 (de) 2008-04-30
DK1496876T3 (da) 2008-06-02
HK1078793A1 (en) 2006-03-24
PE20030970A1 (es) 2004-01-13
TWI344851B (en) 2011-07-11
CN1646108A (zh) 2005-07-27
EA007228B1 (ru) 2006-08-25
ATE389391T1 (de) 2008-04-15
JP2005531528A (ja) 2005-10-20
AR039286A1 (es) 2005-02-16
EP1949892A1 (de) 2008-07-30
WO2003084519A3 (de) 2003-12-24
AU2003222791B2 (en) 2008-09-25
CA2473815A1 (en) 2003-10-16
UY27754A1 (es) 2003-11-28
EP1496876B1 (de) 2008-03-19
AU2003222791A1 (en) 2003-10-20
KR20040097322A (ko) 2004-11-17
HRP20040932A2 (en) 2005-02-28
EP1496876A2 (de) 2005-01-19
PL371204A1 (en) 2005-06-13
CY1108133T1 (el) 2014-02-12
UA78994C2 (uk) 2007-05-10
MY137249A (en) 2009-01-30
CA2473815C (en) 2011-06-14
EA200401305A1 (ru) 2005-06-30
CN1309378C (zh) 2007-04-11
PT1496876E (pt) 2008-04-15
RS50923B (sr) 2010-08-31
RS87904A (sr) 2006-12-15

Similar Documents

Publication Publication Date Title
CO5611150A2 (es) Formulacion en aerosol de una sal de tiotropio de administracion directa para inhalacion
ES2620413T3 (es) Formulaciones veterinarias antihelmínticas tópicas
CO6150127A2 (es) Formulaciones de flibanserina y metodo para fabricarlas
JP2020007356A5 (https=)
AR067184A1 (es) Uso de 6-(3-cloro-2-fluorbencil)-1-[(2s)-1-hidroxi-3-metilbutan-2-il]-7-metoxi-4-oxo-1,4-dihidroquinolina-3-carboxilico. composicion farmaceutica
PE20030399A1 (es) Formas de administracion de propiverina o sus sales farmaceuticamente aceptables con liberacion prolongada de la sustancia activa
KR20000068528A (ko) 4,5-에폭시모르피난 유도체를 함유하는 안정한 의약품 조성물
AR082049A1 (es) Formulaciones liquidas de rupatadina fumarato
CO5251448A1 (es) Soluciones que contienen epinastina
AR119974A1 (es) Composición radiofarmacéutica concentrada, estable
AR040248A1 (es) Farmaco para el tratamiento de la vejiga hiperactiva
CN104274398A (zh) 一种含阿苯达唑悬浮剂及其制备方法
ES2383433T3 (es) Formulación farmacéutica de apomorfina para administración bucal
JP2014237607A (ja) ペメトレキセドを含む注射用組成物
KR20090057400A (ko) 트롬빈 수용체 길항제의 동결건조된 신속 붕해성 경구 제형
AR006892A1 (es) Uso de formas del acido hialuronico (ha) para el tratamiento del cancer
IL303817A (en) Preparations for enhanced transport of CGRP inhibitors
JP6501399B2 (ja) ペメトレキセドを含有する注射用溶液製剤
AR085273A1 (es) Formulacion liquida libre de propelente que comprende una droga antimuscarinica
JP2005531528A5 (https=)
ES3049195T3 (en) Pharmaceutical capsule composition of rivaroxaban
ES2791775A2 (es) Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades
BR0013283A (pt) Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo
CO5021217A1 (es) Composiciones estables de mitoxantrona, procedimietno para prepararlas; utilizacion de dichas composiciones y medica- mentos que incluyen dichas soluciones para el tratamiento de enfermedades cancerosas
CA3202137A1 (en) Compositions for improved delivery of cgrp inhibitors

Legal Events

Date Code Title Description
FG Application granted